AT1 FY21 - General Discussion + FA, page-1830

No, not a good idea at all, as a biased shareholder of a publicly listed company, to try pressuring public health depts and elected officials to fast track actions that will end up materially benefitting oneself.

If AT1-AccBio diagnosis product and submission is good enough, it will get approved (eventually). If it takes a long time or doesn't get approved at all, then something is lacking and needs to be fixed by the company...not get pushed to be approved like many other crap RATs also being shoved into the market.